Fresenius | FRE - Текущие активы





Текущие активы Изменить Дата
Akzo Nobel EUR 8.12B 594M 2026-06
Alcon AG USD 6.62B 4M 2026-06
AstraZeneca USD 27.97B 1.65B 2026-06
BASF EUR 38.79B 1.18B 2026-06
Bayer EUR 33.64B 1.66B 2026-06
Beiersdorf EUR 6.66B 8M 2025-12
DaVita Healthcare Partners USD 4.19B 126.96M 2026-06
Demant DKK 10.2B 130M 2026-06
E.ON EUR 26.75B 1.28B 2026-06
Essilor EUR 11.24B 770M 2026-06
Fresenius EUR 11.61B 456M 2026-06
Fresenius Medical Care EUR 7.69B 418.66M 2026-06
Getinge SEK 15.77B 2.39B 2026-06
Givaudan CHF 4.07B 258M 2025-12
GlaxoSmithKline GBP 17.56B 202M 2026-06
GN Store Nord DKK 5.63B 783M 2026-06
GRIFOLS EUR 5.31B 51M 2026-06
Hikma Pharmaceutical USD 2.64B 86M 2025-12
Lonza CHF 8B 3.41B 2025-12
Merck EUR 13.77B 393M 2026-06
Novartis USD 27.35B 744M 2026-06
Philips EUR 9.33B 454M 2026-06
Roche Holding CHF 35.44B 3.29B 2026-06
RWE EUR 41.55B 4.05B 2026-06
Sanofi EUR 31.52B 1.36B 2026-06
Smith & Nephew USD 4.39B 240M 2026-06